The neural cell adhesion molecule-derived peptide, FGL, Attenuates lipopolysaccharide-induced changes in glia in a CD200-dependent manner

Neuroscience

Volumn 235, Issue , 2013, Pages 141-148

  Cox, F F ^a   Berezin, V ^b   Bock, E ^b   Lynch, M A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Astrocytes; CD11b; CD200; Fibroblast growth loop (FGL); Inflammatory cytokines; Microglial activation

Indexed keywords

CD11B ANTIGEN; CD200 ANTIGEN; CD40 ANTIGEN; FIBROBLAST GROWTH LOOP; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NERVE CELL ADHESION MOLECULE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; GLIA; INFLAMMATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; ASTROCYTES; BIOLOGICAL MARKERS; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROGLIA; PEPTIDES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84874355948     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.12.030     Document Type: Article

References (29)

1. Broderick C., Hoek R.M., Forrester J.V., Liversidge J., Sedgwick J.D., Dick A.D. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol 2002, 161:1669-1677.
2. Cambon K., Hansen S.M., Venero C., Herrero A.I., Skibo G., Berezin V., Bock E., Sandi C. A synthetic neural cell adhesion molecule mimetic peptide promotes synaptogenesis, enhances presynaptic function, and facilitates memory consolidation. J Neurosci 2004, 24:4197-4204.
3. Campbell I.K., Hamilton J.A., Wicks I.P. Collagen-induced arthritis in C57BL/6 (H-2b) mice. new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 2000, 30:1568-1575.
4. Copland D.A., Calder C.J., Raveney B.J., Nicholson L.B., Phillips J., Cherwinski H., Jenmalm M., Sedgwick J.D., Dick A.D. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am J Pathol 2007, 171:580-588.
5. Costello D.A., Lyons A., Denieffe S., Browne T.C., Cox F.F., Lynch M.A. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice. a role for Toll-like receptor activation. J Biol Chem 2011, 286:34722-34732.
6. Cowley T.R., O'Sullivan J., Blau C., Deighan B.F., Jones R., Kerskens C., Richardson J.C., Virley D., Upton N., Lynch M.A. Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP. Neurobiol Aging 2012, 33:162-175.
7. Cox F.F., Carney D., Miller A.M., Lynch M.A. CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Behav Immun 2012, 26:789-796.
8. Dallerac G., Zerwas M., Novikova T., Callu D., Leblanc-Veyrac P., Bock E., Berezin V., Rampon C., Doyere V. The neural cell adhesion molecule-derived peptide FGL facilitates long-term plasticity in the dentate gyrus in vivo. Learn Mem 2011, 18:306-313.
9. Downer E.J., Cowley T.R., Cox F., Maher F.O., Berezin V., Bock E., Lynch M.A. A synthetic NCAM-derived mimetic peptide, FGL, exerts anti-inflammatory properties via IGF-1 and interferon-gamma modulation. J Neurochem 2009, 109:1516-1525.
10. Downer E.J., Cowley T.R., Lyons A., Mills K.H., Berezin V., Bock E., Lynch M.A. A novel anti-inflammatory role of NCAM-derived mimetic peptide, FGL. Neurobiol Aging 2010, 31:118-128.
11. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000, 25:1439-1451.
12. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., Blom B., Homola M.E., Streit W.J., Brown M.H., Barclay A.N., Sedgwick J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290:1768-1771.
13. Kiselyov V.V., Skladchikova G., Hinsby A.M., Jensen P.H., Kulahin N., Soroka V., Pedersen N., Tsetlin V., Poulsen F.M., Berezin V., Bock E. Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure 2003, 11:691-701.
14. Klementiev B., Novikova T., Novitskaya V., Walmod P.S., Dmytriyeva O., Pakkenberg B., Berezin V., Bock E. A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35. Neuroscience 2007, 145:209-224.
15. Li S., Christensen C., Kohler L.B., Kiselyov V.V., Berezin V., Bock E. Agonists of fibroblast growth factor receptor induce neurite outgrowth and survival of cerebellar granule neurons. Dev Neurobiol 2009, 69:837-854.
16. Luo X.G., Zhang J.J., Zhang C.D., Liu R., Zheng L., Wang X.J., Chen S.D., Ding J.Q. Altered regulation of CD200 receptor in monocyte-derived macrophages from individuals with Parkinson's disease. Neurochem Res 2010, 35:540-547.
17. Lyons A., Downer E.J., Crotty S., Nolan Y.M., Mills K.H., Lynch M.A. CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J Neurosci 2007, 27:8309-8313.
18. Lyons A., McQuillan K., Deighan B.F., O'Reilly J.A., Downer E.J., Murphy A.C., Watson M., Piazza A., O'Connell F., Griffin R., Mills K.H., Lynch M.A. Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide. Brain Behav Immun 2009, 23:1020-1027.
19. Miller AM, Deighan BF, Downer E, Lyons A, Henrich-Noack P, Nolan Y, Lynch MA (2011) Analysis of the Impact of CD200 on Neurodegenerative Diseases.In: Raymond Chuen-Chung Chang (Ed.), Neurodegenerative Diseases - Processes, Prevention, Protection and Monitoring. ISBN: 978-953-307-485-6, InTech, Available from: <>. http://www.intechopen.com/books/neurodegenerative-diseases-processes-prevention-protection-and-monitoring/analysis-of-the-impact-of-cd200-on-neurodegenerative-diseases.
20. Minogue A.M., Barrett J.P., Lynch M.A. LPS-induced release of IL-6 from glia modulates production of IL-1 beta in a JAK2-dependent manner. J Neuroinflamm 2012, 9:126.
21. Neiiendam J.L., Kohler L.B., Christensen C., Li S., Pedersen M.V., Ditlevsen D.K., Kornum M.K., Kiselyov V.V., Berezin V., Bock E. An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons. J Neurochem 2004, 91:920-935.
22. Ojo B., Rezaie P., Gabbott P.L., Cowely T.R., Medvedev N.I., Lynch M.A., Stewart M.G. A neural cell adhesion molecule-derived peptide, FGL, attenuates glial cell activation in the aged hippocampus. Exp Neurol 2011, 232:318-328.
23. Ojo B., Rezaie P., Gabbott P.L., Davies H., Colyer F., Cowley T.R., Lynch M., Stewart M.G. Age-related changes in the hippocampus (loss of synaptophysin and glial-synaptic interaction) are modified by systemic treatment with an NCAM-derived peptide, FGL. Brain Behav Immun 2012, 26:778-788.
24. Skibo G.G., Lushnikova I.V., Voronin K.Y., Dmitrieva O., Novikova T., Klementiev B., Vaudano E., Berezin V.A., Bock E. A synthetic NCAM-derived peptide, FGL, protects hippocampal neurons from ischemic insult both in vitro and in vivo. Eur J Neurosci 2005, 22:1589-1596.
25. Snelgrove R.J., Goulding J., Didierlaurent A.M., Lyonga D., Vekaria S., Edwards L., Gwyer E., Sedgwick J.D., Barclay A.N., Hussell T. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 2008, 9:1074-1083.
26. Solovjov D.A., Pluskota E., Plow E.F. Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem 2005, 280:1336-1345.
27. Walker D.G., Dalsing-Hernandez J.E., Campbell N.A., Lue L.F. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation. Exp Neurol 2009, 215:5-19.
28. Wang X.J., Ye M., Zhang Y.H., Chen S.D. CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease. J Neuroimmune Pharmacol 2007, 2:259-264.
29. Watson M.B., Costello D.A., Carney D.G., McQuillan K., Lynch M.A. SIGIRR modulates the inflammatory response in the brain. Brain Behav Immun 2010, 24:985-995.